IL6 and metabolic dysfunction-associated steatotic liver disease: A cross-sectional study (Rodrigues et al., 2014) found that serum IL-6 and TNFα levels in postmenopausal NAFLD patients with metabolic syndrome were higher than those in the control group, suggesting that estrogen deficiency would promote or aggravate the development of NAFLD.